Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| 6 acute adverse affects of systemic glucocorticoid therapy: |
|
Definition
1. hyperglycemia
2. water retention
3. >appitite
4. >infections
5. 6. CNS effects |
|
|
Term
| list the GLucocorticoids and the equipotent doses: |
|
Definition
1. hydrocortisone 20
2. cortisone 25
3. prednisone 5
4. prednisolone 5
5. methylprednisone 4
6. triamcinolone 4
7. betamethasone 0.6-0.75
8. dexamethasone 0.75 |
|
|
Term
| tapering steroids is not usually necessary for courses < __ unless __- |
|
Definition
|
|
Term
| long course of steroids is considered to be: |
|
Definition
|
|
Term
| HPA suppression can occur with these doses of steroids:" |
|
Definition
| long duration and short courses of high doses |
|
|
Term
| list steroid vehicle form strongest to weakest potency |
|
Definition
| Ointment>cream>lotion>gels |
|
|
Term
| how to prevent tachyphylaxis: |
|
Definition
| intermittent dosing; once lesion is suppressed switch to weekly dosing |
|
|
Term
| max tx duration for high potency topical steroids: |
|
Definition
|
|
Term
| max tx duration for high & intermediate potency topical steroids: |
|
Definition
|
|
Term
| 5 adverse effecets of topical steroids: |
|
Definition
1. skin atrophy
2. striae
3. rosacea
4. hypopigmentation
5. allergic contact dermatitis |
|
|
Term
| 4 levels of potency for topical steroids: |
|
Definition
1. very high
2. high
3. intermediate
4. low |
|
|
Term
| 4 adverse effects of inhaled corticosteroids: |
|
Definition
1. thrush
2. dystonia
3. cough
4. growth delay (temporary)
5. systemic effects |
|
|
